Por: RTTNews Health September 24, 2022
Shares of Eloxx Pharmaceuticals, Inc. () are down over 42% at $0.22 in premarket trading session on Thursday, following disappointing results from the company's phase II combination trial of ELX-02 in Class 1 cystic fibrosis patients.The phase II combination clinical trial was designed to evaluate safety and assess biological activity of of ELX-02 in Class 1 cystic fibrosis patients as monotherapy and in combination with Ivacaftor.The trial... + full article
10 WBNS USA Health October 06, 2022
LOUISVILLE, Ky. — A father in Carmel is continuing his mission to prolong his 3-year-old son's life by to raise money for the Cystic Fibrosis Foundation. 's life includes a devastating genetic disorder. Doctors diagnosed him with cystic fibrosis through a blood... + más
Neat to sweet, Orlando craft cocktail pros celebrate Bourbon Heritage Month | Orlando Sentinel
Kentucky Bourbon Trail on pace to surpass record-high number of distillery visitations in a year | Fox Business
RTTNews USA Health October 03, 2022
Shares of Prometheus Biosciences Inc. () closed at an all-time high of $59.01 on Friday (Sep.30, 2022), reflecting a gain of over 100% in 3 months.Prometheus is a biotechnology company pioneering a precision medicine approach in developing novel therapeutic and companion... + más
Dodgers Dugout: Will the next Dodgers closer please stand up? | Los Angeles Times
Brayan Bello stumbles to cap promising rookie campaign and Red Sox again steamrolled by Blue Jays | The Boston Globe
Los Angeles Times USA Opinion October 02, 2022
If you’re a woman or person of color, your health is being hurt by a lack of diversity in healthcare. I suddenly realized that a few years ago at a conference for pharma executives. Dr. Lynn Seely, who was then the female chief executive officer of Myovant, a biopharmaceutical... + más
Council Post: How A Diverse Board Can Help Your Company | Forbes
Jody Rose and Jeff Bussgang are tackling tech’s diversity problem | The Boston Globe
Forbes USA Business September 30, 2022
, VP and Business Leader, Infovision Social—the Research, Digital Experience, Social Media Analytics arm of InfoVision. getty Social media has opened up a whole new dimension of insights for pharma companies. The conversations happening in social media are real-world... + más
Council Post: 10 Areas To Dedicate The Bulk Of Your Social Media Budget To (And Why) | Forbes
Cadence Brings Big Data And AI Analytics To SoC Verification | Forbes
Forbes USA Business September 24, 2022
Following another ugly market week, the average U.S. stock is now trading in Bear Market territory. Of course, such was also the case in 2020 and 2018 and 2016 and more than a few other periods throughout market history. Such is the hardship that must be endured to achieve... + más
What is storm surge, and what contributes to the deadly hurricane hazard? | CBS News
Early-adopter tax is in full force for the first batch of AM5 motherboards | Ars Technica
Business Insider USA Business September 22, 2022
Over the last ten years, the rise in popularity for fractional shares has helped to usher in a wave of new investors. Fractional shares along with the subsequent rise in commission-free trading paved the way for a record number of young, first-time investors to enter the... + más
Brenden Aaronson: I want to become a Leeds club legend | Bleacher Report
Volkswagen sets Porsche IPO at up to 9.4 billion euros | ABC News
Chicago Tribune USA Health September 22, 2022
Although he received a double lung transplant last year, when Edgardo Diaz became sick with COVID-19 in April, he showed no fear. “I wasn’t scared,” said the 30-year-old Oak Forest resident. “I’ve been through worse.” Diaz has cystic fibrosis, a disorder that causes... + más
'Survivor' returns with a new group of contestants on September 21 — here's how to watch the latest season | Business Insider
Triple H Reveals WWE Survivor Series to Feature 2 WarGames Matches for 1st Time Ever | Bleacher Report
About iurex | Privacy Policy | Disclaimer |